Brief Title
Bridging Hemophilia B Experiences, Results and Opportunities Into Solutions (B-HERO-S)
Official Title
Bridging Hemophilia B Experiences, Results and Opportunities Into Solutions (B-HERO-S)
Brief Summary
This study is conducted in the United States of America (USA). Tha aim of this study is bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S).
Study Type
Observational
Primary Outcome
An online survey of Prevalence and characteristics of adults with hemophilia B
Secondary Outcome
Percentage of participants reporting difficulty with access to treatment (e.g. factor)
Condition
Haemostasis
Intervention
No treatment given
Study Arms / Comparison Groups
Survey
Description:
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Other
Estimated Enrollment
449
Start Date
September 2015
Completion Date
November 2015
Primary Completion Date
November 2015
Eligibility Criteria
Inclusion Criteria: - Adults aged below or equal to 18 years with hemophilia B (any severity, with or without inhibitors) - Caregivers of children currently aged below 18 years with hemophilia B (any severity, with or without inhibitors) - Subjects must have access to the internet, either at home or at a location convenient to them - Provision of informed consent before the start of any survey-related activities Exclusion Criteria: - Inability to understand and comply with written instructions in English - Previous completion of the B-HERO-S study with receipt of compensation - Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
Gender
All
Ages
18 Years - N/A
Accepts Healthy Volunteers
No
Contacts
Global Clinical Registry (GCR, 1452), ,
Location Countries
United States
Location Countries
United States
Administrative Informations
NCT ID
NCT02568202
Organization ID
HAEM-4268
Secondary IDs
U1111-1171-8168
Responsible Party
Sponsor
Study Sponsor
Novo Nordisk A/S
Study Sponsor
Global Clinical Registry (GCR, 1452), Study Director, Novo Nordisk A/S
Verification Date
January 2016